Impact of the First SARS-CoV-2 Lockdown on Adherence to Biological Treatment in Patients with Immune-Mediated Inflammatory Diseases in the Netherlands

Romy van der Groef,1 Pascal HP de Jong,1 Dirk Jan Hijnen,2 Christien J van der Woude,3 Jan AM van Laar,4 P Hugo M van der Kuy,5 Jan-Dietert Brugma,6 Annelieke Pasma1 1Department of Rheumatology, Erasmus University Medical Center, Rotterdam, the Netherlands; 2Department of Dermatology, Erasmus University Medical Center, Rotterdam, the Netherlands; 3Department of Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam, the Netherlands; 4Department of Internal Medicine and Immunology, Erasmus University Medical Center, Rotterdam, the Netherlands; 5Department of Clinical Phar... Mehr ...

Verfasser: van der Groef R
de Jong PHP
Hijnen DJ
van der Woude CJ
van Laar JAM
van der Kuy PHM
Brugma JD
Pasma A
Dokumenttyp: Artikel
Erscheinungsdatum: 2023
Reihe/Periodikum: Patient Preference and Adherence, Vol Volume 17, Pp 167-174 (2023)
Verlag/Hrsg.: Dove Medical Press
Schlagwörter: adherence / biological / sars-cov-2 / immune-mediated inflammatory diseases / Medicine (General) / R5-920
Sprache: Englisch
Permalink: https://search.fid-benelux.de/Record/base-26804454
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : https://doaj.org/article/ea7b8f7f9d1f4f70a3b208ee8d989c06